About Elbrit Life Sciences
Elbrit Life Sciences is a Healthcare company based in Mumbai (India) founded in 2014. It operates as a develops, manufactures, and distributes innovative medications for various health conditions worldwide. It operates on a B2B model. The company has 213 employees. Its Indian entity Elbrit Life Sciences Private Limited reported revenue of ₹41.77 Cr. Elbrit Life Sciences offers products and services including Cardiovascular Medications, Diabetes Medications, Gastroenterology Medications, Neuropathy Medications, and Neuropsychiatry Medications. Its focus areas include Pharmaceuticals, Research and Development, Innovation in Therapies and Drug Manufacturing. Its competitors include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx and 3 more; 4 of its 8 listed competitors have raised funding.
Company details
Elbrit Life Sciences is a pharmaceutical company based in India that focuses on developing and manufacturing medications for therapies like cardiovascular and diabetes. They emphasize innovation, research, and partnerships with healthcare providers to deliver quality products. With offices in Mumbai, Chennai, and Bengaluru, they distribute cutting-edge treatments and aim for global expansion while prioritizing patient wellbeing and environmental responsibility.
- Headquarters Mumbai, India
- Employees 213
- SectorsHealthcare
- Phone•••• ••••
- Website elbrit.org
- Social LinkedIn X Facebook Instagram
- Legal Name Elbrit Life Sciences Private Limited
- Date of Incorporation 18 Jan, 2014
- Jurisdiction Erode, Tamil Nadu, India
- Annual Revenue₹41.77 Cr
FY 2024 · +39% YoY
- Net Profit₹1.16 Cr
FY 2024 · 3% margin
- EBITDA₹3.05 Cr
FY 2024 · 7% margin
- Employee Count213
Associated legal entities of Elbrit Life Sciences
Elbrit Life Sciences operates through Elbrit Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Elbrit Life Sciences Private Limited CIN U74999TZ2014PTC029965 | Active | 18 Jan 2014 | Erode, Tamil Nadu | ₹41.8 Cr | 213 | 4 | View details |
Products & Services of Elbrit Life Sciences
Elbrit Life Sciences offers a comprehensive portfolio of products and services, including Cardiovascular Medications, Diabetes Medications, Gastroenterology Medications, Neuropathy Medications, and Neuropsychiatry Medications.
Treats heart-related conditions through innovative drug formulations.
Manages blood sugar levels with advanced pharmaceutical solutions.
Addresses digestive disorders using research-based treatments.
Alleviates nerve damage symptoms with effective drug options.
Supports mental health conditions through targeted therapies.
Board of directors of Elbrit Life Sciences Private Limited (Elbrit Life Sciences)
Elbrit Life Sciences Private Limited is the primary company behind Elbrit Life Sciences. The board of Elbrit Life Sciences Private Limited currently have 4 directors; the longest-serving is Senthilkumar Kailasanathan, appointed in 2014. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Senthilkumar Kailasanathan DIN 06751926 | Whole-time director | 18 Jan 2014 | 12 yrs 9 mo | Elbrit Life Sciences Private Limited |
| Kailasanathan Senthilkumar Prakash DIN 06751916 | Managing Director | 18 Jan 2014 | 12 yrs 9 mo | Elbrit Life Sciences Private Limited |
| Karukkupalayam Murugesan Nivedha DIN 09139103 | Whole-time director | 09 Apr 2021 | 5 yrs 6 mo | Elbrit Life Sciences Private Limited |
| Muruhgesan Marappagounder DIN 07900558 | Director | 30 Aug 2024 | 2 yrs 1 mo | Elbrit Life Sciences Private Limited |
Financials of Elbrit Life Sciences
Figures of Elbrit Life Sciences Private Limited, the primary company behind Elbrit Life Sciences, for FY 2024. Revenue was ₹41.77 Cr (+39% year on year). Net profit was ₹1.16 Cr (3% margin). EBITDA was ₹3.05 Cr (7% margin). Revenue has grown at a compounded annual rate of +42% over three years and +26% over five years.
- ₹41.77 CrRevenue · FY 2024 · +39% YoY
- ₹1.16 CrNet profit · 3% margin
- ₹3.05 CrEBITDA · 7% margin
- ₹75.2 LakhPaid-up capital
- 213Employees (provident fund records)
- +42%Revenue CAGR, 3 years
- +26%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Elbrit Life Sciences Private Limited are on its company page.
Detailed financial statements for Elbrit Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Elbrit Life Sciences
Elbrit Life Sciences has 8 listed competitors in our database, 4 of them funded. They include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| medpharm.com | 1998 | Guildford, United Kingdom | – | 108 | Topical and inhaled drug delivery formulations are developed and manufactured. |
Detailed competitors of Elbrit Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Elbrit Life Sciences
The website of Elbrit Life Sciences (elbrit.org) receives about 1.2K visits a month.
- Monthly visits1.2K
▼ 8.1% vs previous month
Top companies in Clinical Trials & Research Tech
10 companies that operate in the same segment as Elbrit Life Sciences (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 617.6 M | – | 252 | |
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | – | 22 | |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | – | USD 50.52 M | 902 | |
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | – | USD 4.22 M | 228 | |
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | – | 25 | |
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M | – | – | |
Laboratory delivers discovery & research in nuclear and particle physics | 1947 | United States | – | – | 2,436 | |
Research and manufacturing of hemp products are conducted by BRC. | 2017 | Monterey, California, United States | USD 25.26 M | – | 16 | |
Genome sequencing studies are conducted for medical research purposes. | 2020 | Cambridge, Cambridgeshire, United Kingdom | USD 11.26 M | – | 12 | |
Novel immunotherapy therapeutic targets are discovered through laboratory research. | 2019 | Branford, Connecticut, United States | USD 92 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Elbrit Life Sciences
Complete news archive for Elbrit Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elbrit Life Sciences
Elbrit Life Sciences was founded in 2014.
Elbrit Life Sciences is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Elbrit Life Sciences has 213 employees.
The primary company behind Elbrit Life Sciences, Elbrit Life Sciences Private Limited, reported revenue of ₹41.77 Cr for FY 2024, up 39% year on year.
Elbrit Life Sciences is a pharmaceutical company based in India that focuses on developing and manufacturing medications for therapies like cardiovascular and diabetes. They emphasize innovation, research, and partnerships with healthcare providers to deliver quality products. With offices in Mumbai, Chennai, and Bengaluru, they distribute cutting-edge treatments and aim for global expansion while prioritizing patient wellbeing and environmental responsibility.
Elbrit Life Sciences's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Elbrit Life Sciences offers Cardiovascular Medications, Diabetes Medications, Gastroenterology Medications, Neuropathy Medications, and Neuropsychiatry Medications.
Elbrit Life Sciences operates through Elbrit Life Sciences Private Limited.
The legal entities of Elbrit Life Sciences currently have 4 directors, including Muruhgesan Marappagounder, Karukkupalayam Murugesan Nivedha, Senthilkumar Kailasanathan and others.